Recent research highlights the role of fibrinogen in promoting acute myelogenous leukemia progression through the miR-486/GPR153 axis. This discovery may open new avenues for targeted therapies in AML.
fibrinogen promotes acute myelogenous leukemia progression via mir 486 gpr153 axis
Original title: “Fibrinogen promotes acute myelogenous leukemia progression via miR-486/GPR153 axis.”